The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts

Cardiovascular Research

Volumn 70, Issue 2, 2006, Pages 384-390

  Turan, Nilufer ^a   Csonka, Csaba ^c   Csont, Tamás ^c   Giricz, Zoltán ^c   Fodor, Gabriella ^c   Bencsik, Péter ^c   Gyöngyösi, Mariann ^b   Cakici, Iclal ^a   Ferdinandy, Péter ^c,d  

^a GAZI UNIVERSITY   (Turkey)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF SZEGED   (Hungary)

^d Pharmahungary 2000 Ltd   (Hungary)

Author keywords

3 nitropropionic acid; Chemical preconditioning; Heart; NADH oxidase; Nitric oxide; Peroxynitrite; Rat; Superoxide; Xanthine oxidoreductase

Indexed keywords

3 NITROPROPIONIC ACID; 3 NITROTYROSINE; LACTATE DEHYDROGENASE; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME RELEASE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; REPERFUSION;

ANIMALS; BIOLOGICAL MARKERS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRO COMPOUNDS; PEROXYNITROUS ACID; PROPIONIC ACIDS; RATS; RATS, WISTAR; SUCCINATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; TYROSINE; XANTHINE OXIDASE;

EID: 33646485807     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.12.012     Document Type: Article

References (29)

1. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74 (1986) 1124-1136
2. Ferdinandy P., Szilvassy Z., and Baxter G.F. Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon?. Trends Pharmacol Sci 19 (1998) 223-229
3. Ferdinandy P., and Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138 (2003) 532-543
4. Altug S., Demiryurek A.T., Kane K.A., and Kanzik I. Evidence for the involvement of peroxynitrite in ischaemic preconditioning in rat isolated hearts. Br J Pharmacol 130 (2000) 125-131
5. Altup S., Demiryurek A.T., Ak D., Tungel M., and Kanzuk I. Contribution of peroxynitrite to the beneficial effects of preconditioning on ischaemia-induced arrhythmias in rat isolated hearts. Eur J Pharmacol 415 (2001) 239-246
6. Csonka C., Szilvassy Z., Fulop F., Pali T., Blasig I.E., Tosaki A., et al. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation 100 (1999) 2260-2266
7. Csonka C., Csont T., Onody A., and Ferdinandy P. Preconditioning decreases ischemia/reperfusion-induced peroxynitrite formation. Biochem Biophys Res Commun 285 (2001) 1217-1219
8. Riepe M.W., and Ludolph A.C. Chemical preconditioning: a cytoprotective strategy. Mol Cell Biochem 174 (1997) 249-254
9. Ockaili R.A., Bhargava P., and Kukreja R.C. Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial K(ATP) channel. Am J Physiol Heart Circ Physiol 280 (2001) H2406-H2411
10. Horiguchi T., Kis B., Rajapakse N., Shimizu K., and Busija D.W. Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke 34 (2003) 1015-1020
11. Aketa S., Nakase H., Kamada Y., Hiramatsu K., and Sakaki T. Chemical preconditioning with 3-nitropropionic acid in gerbil hippocampal slices: therapeutic window and the participation of adenosine receptor. Exp Neurol 166 (2000) 385-391
12. Rejdak R., Rejdak K., Sieklucka-Dziuba M., Stelmasiak Z., and Grieb P. Brain tolerance and preconditioning. Pol J Pharmacol 53 (2001) 73-79
13. Alston T.A., Mela L., and Bright H.J. 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci U S A 74 (1977) 3767-3771
14. Hassel B., and Sonnewald U. Selective inhibition of the tricarboxylic acid cycle of GABAergic neurons with 3-nitropropionic acid in vivo. J Neurochem 65 (1995) 1184-1191
15. Nandagopal K., Dawson T.M., and Dawson V.L. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J Pharmacol Exp Ther 297 (2001) 474-478
16. Borlongan C.V., Koutouzis T.K., and Sanberg P.R. 3-nitropropionic acid animal model and Huntington's disease. Neurosci Biobehav Rev 21 (1997) 289-293
17. Schulz J.B., Henshaw D.R., MacGarvey U., and Beal M.F. Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity. Neurochem Int 29 (1996) 167-171
18. Wang J., Green P.S., and Simpkins J.W. Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J Neurochem 77 (2001) 804-811
19. Teunissen C.E., Markerink-van Ittersum M., Bruijn De C., Steinbusch H.W., and de Vente J. Evaluation of 3-nitrotyrosine as a marker for 3-nitropropionic acid-induced oxidative stress in Lewis and Wistar rats and strain-specific whole brain spheroid cultures. Brain Res 931 (2002) 5-20
20. Schulz J.B., Matthews R.T., Klockgether T., Dichgans J., and Beal M.F. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol Cell Biochem 174 (1997) 193-197
21. Onody A., Csonka C., Giricz Z., and Ferdinandy P. Hyperlipidemia induced by a cholesterol-rich diet leads to enhanced peroxynitrite formation in rat hearts. Cardiovasc Res 58 (2003) 663-670
22. 2+-independent nitric-oxide synthase in the myocardium. Br J Pharmacol 105 (1992) 575-580
23. Beckman J.S., Parks D.A., Pearson J.D., Marshall P.A., and Freeman B.A. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic Biol Med 6 (1989) 607-615
24. von Arnim C.A., Timmler M., Ludolph A.C., and Riepe M.W. Chemical preconditioning in mice is not mediated by upregulation of nitric oxide synthase isoforms. Neurosci Lett 299 (2001) 130-134
25. Riepe M.W., Schmalzigaug K., Fink F., Oexle K., and Ludolph A.C. NADH in the pyramidal cell layer of hippocampal regions CA1 and CA3 upon selective inhibition and uncoupling of oxidative phosphorylation. Brain Res 710 (1996) 21-27
26. Riepe M.W., Esclaire F., Kasischke K., Schreiber S., Nakase H., Kempski O., et al. Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation: "chemical preconditioning". J Cereb Blood Flow Metab 17 (1997) 257-264
27. Beal M.F., Ferrante R.J., Henshaw R., Matthews R.T., Chan P.H., Kowall N.W., et al. 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice. J Neurochem 65 (1995) 919-922
28. Nakagawa I., Nakase H., Aketa S., Kamada Y., Yamashita M., and Sakaki T. ATP-dependent potassium channel mediates neuroprotection by chemical preconditioning with 3-nitropropionic acid in gerbil hippocampus. Neurosci Lett 320 (2002) 33-36
29. Nakagawa I., Ogawa Y., Noriyama Y., Nakase H., Yamashita M., and Sakaki T. Chemical preconditioning prevents paradoxical increase in glutamate release during ischemia by activating ATP-dependent potassium channels in gerbil hippocampus. Exp Neurol 183 (2003) 180-187